Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01263067 · ClinicalTrials.gov registry record · NA

Lifespan Integration for Posttraumatic Stress Disorder From an Auto Accident

A NA study of Posttraumatic Stress Disorder, sponsored by Argosy University.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT01263067 is a NA study of Posttraumatic Stress Disorder that has completed, run by Argosy University. The registered enrollment target is 6 participants, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01263067, a NA study of Posttraumatic Stress Disorder, has completed, sponsored by Argosy University.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate if lifespan integration (LI) therapy reduces posttraumatic stress symptoms following a motor vehicle accident (MVA) trauma

Interventions

  • BEHAVIORAL Lifespan Integration Therapy
  • BEHAVIORAL Lifespan Integration- Control

Study Locations (1)

Washington

  • Argosy University Seattle - Seattle

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2010-10
Est. Completion 2012-01
Phase NA

Sponsor

Argosy University

1 total trials

What the Registry Record Tells You About NCT01263067

The ClinicalTrials.gov registry entry for NCT01263067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (95% lower). The listed sponsor is Argosy University, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Lifespan Integration Therapy is the first listed.

NCT01263067 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01263067 about?

NCT01263067 is a clinical study titled "Lifespan Integration for Posttraumatic Stress Disorder From an Auto Accident". The purpose of this study is to evaluate if lifespan integration (LI) therapy reduces posttraumatic stress symptoms following a motor vehicle accident (MVA) trauma

What is the current status of trial NCT01263067?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2010-10. Estimated completion is 2012-01.

What conditions does trial NCT01263067 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT01263067?

The interventions under investigation include: Lifespan Integration Therapy (BEHAVIORAL), Lifespan Integration- Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT01263067?

This trial is sponsored by Argosy University, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01263067 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Posttraumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.